Brain

Cerevance Announces Presentation at the 22nd Society of Chemical Industry / Royal Society of Chemistry Medicinal Chemistry Symposium

BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on advancing novel,…

1 year ago

BioVie to Host Virtual KOL Event on NE3107 in Alzheimer’s Disease on September 7, 2023

CARSON CITY, Nev., Aug. 31, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company…

1 year ago

Healing the Wounds of Inflammatory Bowel Disease

A University of Chicago team identified a special type of stem cell that heals damaged bowel tissue in mice, a…

1 year ago

VitalPointTech Announces Acquisition of Herban Healing, LLC, a Revolutionary Bio-Pharmaceutical Company

Herban Healing is dedicated to providing alternative healthcare options to combat the opioid crisisHOUSTON, TX / ACCESSWIRE / August 29,…

1 year ago

Cognetivity Neurosciences Announces Publication of Peer-Reviewed Article Showing Effectiveness of its AI Powered CognICA Technology in Detecting Early-Stage Alzheimer’s Disease

Cognetivity's Landmark ADePT Study, Funded by the UK Innovation Agency and Published in Leading Neuroscience Journal Demonstrates Unprecedented Sensitivity in…

1 year ago

Raymond A. Wood Foundation Reveals Caregiver Burden in Pioneering Craniopharyngioma Study

Unmet Needs and Elevated Risk of Depression: The Challenges Faced by Caregivers of Noncancerous Brain Tumor SurvivorsOCEAN CITY, MD /…

1 year ago

Stress Affects Sex. Male Plus Can Help.

The Natural Libido Enhancer Includes Ginseng as a Way to Reduce Stress.Fort Lauderdale, FL, Aug. 30, 2023 (GLOBE NEWSWIRE) --…

1 year ago

Denali Therapeutics Announces New Interim Data from Phase 1/2 Study of DNL310 (ETV:IDS) in MPS II (Hunter Syndrome) at SSIEM 2023

Additional biomarker data up to two years of treatment continue to demonstrate rapid and sustained normalization of CSF heparan sulfate…

1 year ago

Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients

Claims covering inhibition of 3CL protease, inflammation and autophagy underscore Dr. Dorit Arad’s lifelong work NEW YORK, NY, ALPHARETTA, GA…

1 year ago

Cognition Therapeutics Announces Participation in Upcoming September Conferences

PURCHASE, N.Y., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage neuroscience company developing drugs that treat neurodegenerative…

1 year ago